Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4320 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
Rank Status Study
1 Completed Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Lentivirus Infections;   Retroviridae Infections;   RNA Virus Infections;   Virus Diseases;   Sexually Transmitted Diseases, Viral;   Sexually Transmitted Diseases;   Immunologic Deficiency Syndromes;   Immune System Diseases;   Slow Virus Diseases
Interventions: Procedure: Circumcision;   Procedure: Flexible sigmoidoscopy
2 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
3 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
4 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
5 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
6 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
7 Completed
Has Results
Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population
Condition: Condylomata Acuminata
Intervention:
8 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
9 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
10 Not yet recruiting Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Biological: Ad26.Mos.HIV;   Biological: MVA-Mosaic;   Drug: Placebo
11 Recruiting Supporting Adolescents to Adhere - an Intervention Using Airtime Rewards Allocated by a Prize Drawing
Condition: Human Immunodeficiency Virus
Intervention: Behavioral: Supporting Adolescents to Adhere
12 Not yet recruiting Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: Bivalent Subtype C gp120/MF59 vaccine;   Biological: Bivalent Subtype C gp120/AS01B vaccine;   Biological: Placebo
13 Not yet recruiting Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity
Condition: Genital Herpes Simplex Type 2
Intervention: Other: Non-interventional Study
14 Not yet recruiting Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in HIV-Infected and HIV-Uninfected Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Intervention: Drug: Bedaquiline
15 Not yet recruiting Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE)
Condition: HIV Infections
Intervention: Other: mHealth platform
16 Recruiting Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir
Condition: Chronic HIV Infections
Interventions: Drug: ART plus Chidamide;   Drug: ART plus Placebo
17 Enrolling by invitation mVIP (Use of mHealth Technology for Supporting Symptom Management in Underserved Persons Living With HIV)
Condition: HIV (Human Immunodeficiency Virus)
Interventions: Device: Health Management App with symptom strategies;   Device: My Fitness Pal App
18 Recruiting Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible Tablet
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG/ABC/3TC FDC DISPERSIBLE TABLET;   Drug: EPZICOM (ABC/3TC);   Drug: TIVICAY (DTG)
19 Not yet recruiting Feasibility of an Ingestible Sensor System to Measure PrEP Adherence in YMSM
Condition: Human Immunodeficiency Virus
Intervention: Device: Proteus Sensor System
20 Not yet recruiting iHIVARNA Clinical Trial in HIV Infected Individuals
Condition: HIV Infections
Interventions: Biological: iHIVARNA-01;   Biological: TriMix;   Biological: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years